Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas

Saved in:
Bibliographic Details
Main Authors: Karajannis, Matthias A. (Author) , Pfister, Stefan (Author)
Format: Article (Journal)
Language:English
Published: October 2014
In: Neuro-Oncology
Year: 2014, Volume: 16, Issue: 10, Pages: 1408-1416
ISSN:1523-5866
DOI:10.1093/neuonc/nou059
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1093/neuonc/nou059
Get full text
Author Notes:Matthias A. Karajannis, Geneviève Legault, Michael J. Fisher, Sarah S. Milla, Kenneth J. Cohen, Jeffrey H. Wisoff, David H. Harter, Judith D. Goldberg, Tsivia Hochman, Amanda Merkelson, Michael C. Bloom, Angela J. Sievert, Adam C. Resnick, Girish Dhall, David T. W. Jones, Andrey Korshunov, Stefan M. Pfister, Charles G. Eberhart, David Zagzag and Jeffrey C. Allen

MARC

LEADER 00000caa a2200000 c 4500
001 1526669323
003 DE-627
005 20220812170814.0
007 cr uuu---uuuuu
008 160301s2014 xx |||||o 00| ||eng c
024 7 |a 10.1093/neuonc/nou059  |2 doi 
035 |a (DE-627)1526669323 
035 |a (DE-576)456669329 
035 |a (DE-599)BSZ456669329 
035 |a (OCoLC)1340901534 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Karajannis, Matthias A.  |d 1970-  |e VerfasserIn  |0 (DE-588)12128624X  |0 (DE-627)705358127  |0 (DE-576)292627637  |4 aut 
245 1 0 |a Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas  |c Matthias A. Karajannis, Geneviève Legault, Michael J. Fisher, Sarah S. Milla, Kenneth J. Cohen, Jeffrey H. Wisoff, David H. Harter, Judith D. Goldberg, Tsivia Hochman, Amanda Merkelson, Michael C. Bloom, Angela J. Sievert, Adam C. Resnick, Girish Dhall, David T. W. Jones, Andrey Korshunov, Stefan M. Pfister, Charles G. Eberhart, David Zagzag and Jeffrey C. Allen 
264 1 |c October 2014 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 01.03.2016 
700 1 |a Pfister, Stefan  |d 1974-  |e VerfasserIn  |0 (DE-588)123850215  |0 (DE-627)706450930  |0 (DE-576)293908400  |4 aut 
773 0 8 |i Enthalten in  |t Neuro-Oncology  |d Oxford : Oxford Univ. Press, 1999  |g 16(2014), 10, Seite 1408-1416  |h Online-Ressource  |w (DE-627)357167341  |w (DE-600)2094060-9  |w (DE-576)318041839  |x 1523-5866  |7 nnas  |a Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas 
773 1 8 |g volume:16  |g year:2014  |g number:10  |g pages:1408-1416  |g extent:9  |a Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas 
856 4 0 |u http://dx.doi.org/10.1093/neuonc/nou059  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20160301 
993 |a Article 
994 |a 2014 
998 |g 123850215  |a Pfister, Stefan  |m 123850215:Pfister, Stefan  |d 910000  |d 910500  |e 910000PP123850215  |e 910500PP123850215  |k 0/910000/  |k 1/910000/910500/  |p 17 
999 |a KXP-PPN1526669323  |e 2901431976 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1526669323","id":{"doi":["10.1093/neuonc/nou059"],"eki":["1526669323"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"October 2014"}],"name":{"displayForm":["Matthias A. Karajannis, Geneviève Legault, Michael J. Fisher, Sarah S. Milla, Kenneth J. Cohen, Jeffrey H. Wisoff, David H. Harter, Judith D. Goldberg, Tsivia Hochman, Amanda Merkelson, Michael C. Bloom, Angela J. Sievert, Adam C. Resnick, Girish Dhall, David T. W. Jones, Andrey Korshunov, Stefan M. Pfister, Charles G. Eberhart, David Zagzag and Jeffrey C. Allen"]},"note":["Gesehen am 01.03.2016"],"language":["eng"],"person":[{"given":"Matthias A.","display":"Karajannis, Matthias A.","family":"Karajannis","role":"aut"},{"family":"Pfister","role":"aut","display":"Pfister, Stefan","given":"Stefan"}],"relHost":[{"disp":"Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomasNeuro-Oncology","origin":[{"publisher":"Oxford Univ. Press ; Duke University Medical Center","publisherPlace":"Oxford ; Durham, NC","dateIssuedKey":"1999","dateIssuedDisp":"1999-"}],"id":{"issn":["1523-5866"],"zdb":["2094060-9"],"eki":["357167341"]},"recId":"357167341","type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1999 -"],"note":["Gesehen am 21.07.23"],"language":["eng"],"part":{"extent":"9","issue":"10","year":"2014","pages":"1408-1416","volume":"16","text":"16(2014), 10, Seite 1408-1416"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Neuro-Oncology","subtitle":"official journal of the World Federation of Neuro-Oncology","title_sort":"Neuro-Oncology"}]}],"physDesc":[{"extent":"9 S."}],"title":[{"title_sort":"Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas","title":"Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas"}]} 
SRT |a KARAJANNISPHASEIISTU2014